STC2 and neoplasm: The proliferation of vascular endothelial cells is a key factor affecting tumor-related angiogenesis.21 STC2 inhibition also significantly reduced the HemEC proliferation (Fig.2C) with the reduced protein expression of Proliferating Cell Nuclear Antigen (PCNA), a marker of cell proliferation (Fig.2D and 2E).